Skip to main content
TipRanks
Go Ultimate75% OFF

TRex Bio, Inc. (TRXB) Financial Statements

5 Followers

TRex Bio, Inc. Financial Overview

TRex Bio, Inc.'s market cap is currently $287.89M. The company's EPS TTM is ―; its P/E ratio is -1.52; TRex Bio, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25
Income Statement
Total Revenue$ 0.00
Gross Profit$ 0.00
Operating Income$ -37.84M
EBITDA$ -37.63M
Net Income$ -34.81M
Balance Sheet
Cash & Short-Term Investments$ 67.72M
Total Assets$ 73.13M
Total Debt$ 717.00K
Net Debt$ -14.47M
Total Liabilities$ 165.25M
Stockholders' Equity$ -92.12M
Cash Flow
Free Cash Flow$ -41.43M
Operating Cash Flow$ -41.36M
Investing Cash Flow$ -32.99M
Financing Cash Flow$ 42.07M

Currency in USD

TRex Bio, Inc. Earnings and Revenue History

-45M-30M-15M00 %0.4 %0.8 %1.2 %EarningsProfit Margin2025RevenueEarningsProfit Margin

TRex Bio, Inc. Liabilities to Assets

060M120M180M224 %225 %226 %227 %LiabilitiesLiabilities to Assets2025AssetsLiabilitiesLiabilities to Assets

TRex Bio, Inc. Cash Flow

-60M-40M-20M020M40M60M2025OperatingInvestingFinancing

TRex Bio, Inc. Forecast EPS vs Actual EPS

-12-10-8-6-4-202Q3 26EPS EstimateBeatMiss